Cancer Biology & Therapy

Papers
(The H4-Index of Cancer Biology & Therapy is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma98
Epigenetic silencing L3MBTL4 sensitizes esophageal cancer to DNA-PKcs inhibitor85
Correction71
A novel biochip-based liquid biopsy for extracellular vesicle RNA detection in prostate cancer66
Advances in natural killer cell immunotherapy for hematologic malignancies64
A comparison of cell death pathways in three different kinds of human lung cancer cell lines following hematoporphyrin derivative-mediated photodynamic therapy57
Impact of leucine-rich diet on placenta's proteomic and metabolomic profiles of pregnant tumor-bearing rats50
miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway49
Evaluating massage therapy for radiation-induced fibrosis in rats: preliminary findings and palpation results47
Suppression of LncRNA AC008406.3 sensitizes breast cancer cells to docetaxel via triggering cuproptosis46
Effective treatment of human breast tumors by chimeric CCL2 and CCL8 diphtheria toxin cytotoxic peptides45
DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA1843
Dual role of CXCL10 in cancer progression: implications for immunotherapy and targeted treatment‎39
Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article39
Tripartite motif-containing protein 50 suppresses triple-negative breast cancer progression by regulating the epithelial–mesenchymal transition38
Immunotherapy resistance in solid tumors: mechanisms and potential solutions33
Advancements in exosome-based cancer diagnosis: from chipsets to nano vaccine32
CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells31
The MYBL2-GTSE1 axis promotes laryngeal squamous cell carcinoma progression by regulating PI3K/AKT-dependent glycolytic reprogramming31
GdX inhibits the occurrence and progression of breast cancer by negatively modulating the activity of STAT330
Protein lactylation: molecular mechanisms underlying lactate-driven tumorigenesis and cancer progression29
SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression29
MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer27
Silencing ZIC5 suppresses glycolysis and promotes disulfidptosis in lung adenocarcinoma cells26
Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation26
Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer26
0.67698788642883